BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 233 filers reported holding BEAM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $931,111 | -48.3% | 29,161 | -50.4% | 0.00% | -55.6% |
| Q1 2023 | $1,800,946 | +0.1% | 58,816 | +27.9% | 0.01% | -10.0% |
| Q4 2022 | $1,798,904 | -82.4% | 45,996 | -78.5% | 0.01% | -81.8% |
| Q3 2022 | $10,205,000 | -19.3% | 214,220 | -34.4% | 0.06% | -15.4% |
| Q2 2022 | $12,639,000 | +184.3% | 326,494 | +320.8% | 0.06% | +160.0% |
| Q1 2022 | $4,446,000 | +248.7% | 77,597 | +384.9% | 0.02% | +257.1% |
| Q4 2021 | $1,275,000 | +18.1% | 16,002 | +28.9% | 0.01% | 0.0% |
| Q3 2021 | $1,080,000 | -96.4% | 12,410 | -94.7% | 0.01% | -96.7% |
| Q2 2021 | $30,177,000 | +54.1% | 234,454 | -4.2% | 0.21% | +46.2% |
| Q1 2021 | $19,581,000 | +35.6% | 244,641 | +38.3% | 0.14% | +18.2% |
| Q4 2020 | $14,438,000 | – | 176,848 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $189,105,000 | 91.90% |
| PATHWAY CAPITAL MANAGEMENT, LP | 37,399 | $2,993,000 | 16.59% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,390 | $17,960,000 | 10.54% |
| HSG Holding Ltd | 796,089 | $63,719,000 | 4.73% |
| DC Investments Management, LLC | 21,010 | $1,682,000 | 4.17% |
| Monashee Investment Management LLC | 268,820 | $21,516,000 | 3.31% |
| Redmile Group, LLC | 2,532,523 | $202,703,000 | 2.86% |
| HAMILTON LANE ADVISORS LLC | 98,761 | $7,905,000 | 2.58% |
| Alphabet Inc. | 640,792 | $51,289,000 | 2.07% |
| Casdin Capital, LLC | 818,820 | $65,538,000 | 1.95% |